Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncolo... von Frasci, Giuseppe, Lorusso, Vito, Panza, Nicola, Comella, Pasquale, Nicolella, Gianpaolo, Bianco, Andrea, DeCataldis, Giuseppe, Belli, Mario, Iannelli, Nunzio, Massidda, Bruno, Mascia, Vittorio, Comella, Giuseppe, De Lena, Mario

Volltext

Weekly dose-dense cisplatin-epirubicin- paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease s... von FRASCI, Giuseppe, COMELLA, Pasquale, D'AIUTO, Massimiliano, COMELLA, Giuseppe, CARRECA, Ignazio, DECATALDIS, Giuseppe, MUCI, Domenico, BRUNETTI, Cosimo, RUSSO, Anna, PALMERI, Sergio, D'ANIELLO, Roberta, GIORDANO, Renato

Volltext

Weekly Dose-Dense Cisplatin-Epirubicin-Paclitaxel Administration with Granulocyte Colony-Stimulating Factor Support Does Not Substantially Improve Prognosis in Extensive Disease Sm... von Frasci, Giuseppe, Comella, Pasquale, Carreca, Ignazio, DeCataldis, Giuseppe, Muci, Domenico, Brunetti, Cosimo, Russo, Anna, Palmeri, Sergio, D’Aniello, Roberta, Giordano, Renato, D’Aiuto, Massimiliano, Comella, Giuseppe

Volltext

Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised Phase II trial von Comella, Pasquale, Frasci, Giuseppe, Panza, Nicola, De Cataldis, Giuseppe, Cioffi, Riccardo, Curcio, Carlo, Nicolella, Dario, Micillo, Enrico, Ianniello, Giovanni P., Biondi, Edoardo, Perchard, John, Comella, Giuseppe

Volltext